More bad news has come down for…
More bad news has come down for Biohaven’s small molecule [...]
The director of the National…
The director of the National Institutes of Health has attributed the [...]
After HHS abruptly canceled about…
After HHS abruptly canceled about $500 million in funding for [...]
Another Massachusetts biotech has…
Another Massachusetts biotech has reached the end of the road. [...]
Young inflammatory disease biotech…
Young inflammatory disease biotech Expedition Therapeutics is paying $17 million [...]
IO Biotech’s cancer vaccine has…
IO Biotech’s cancer vaccine has “narrowly” failed to beat Keytruda [...]
The FDA has denied Stealth…
The FDA has denied Stealth BioTherapeutics’ request to reconsider its [...]
After the recent approval and…
After the recent approval and launch of twice-yearly HIV prophylactic [...]
Bicycle Therapeutics is reducing…
Bicycle Therapeutics is reducing its headcount by around 25% to [...]
Longevity company Altos Labs has…
Longevity company Altos Labs has secured a new clinical leader [...]